作为双瘤免疫调节剂的EGR3:一种机器学习驱动的预后标,用于冷乳腺癌
Qianxue Wu1, Daqiang Song1, Jian Yue2
1Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Frontiers in immunology
|December 31, 2025
概括
这项研究确定了乳腺癌预后的3基因特征 (EGR3,RECQL4,MMP1). EGR3作为瘤抑制剂和免疫调节剂,为免疫治疗提供了潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 免疫学 免疫学 免疫学
背景情况:
- 乳腺癌的异质性为治疗和预后带来了挑战.
- 识别新的分子驱动因素和治疗点对于改善患者的治疗结果至关重要.
- 需要强大的预后生物标志物来指导临床决策.
研究的目的:
- 通过综合性多种omics方法识别乳腺癌的关键分子驱动因素.
- 为了验证已识别的分子特征的临床相关性.
- 探索EGR3作为潜在的治疗点的作用.
主要方法:
- 使用了差异基因表达分析,加权基因共表达网络分析 (WGCNA) 和机器学习 (StepCox-Random Survival Forest (RSF)).
- 在多个大规模乳腺癌数据集 (TCGA,GEO,METABRIC) 中选了预后签名.
- 使用单细胞RNA测序和体外/体内实验进行了免疫微环境的表征和机制验证.
主要成果:
- 一个3基因的预后特征 (EGR3,RECQL4,MMP1) 被确定并验证跨队列,显示出优异的预后分层.
- 高风险亚型表现出免疫抑制的微环境与M2巨丰富.
- EGR3被确定为一种瘤抑制剂,与瘤阶段相反相关,并与CD8+T细胞透积极相关,预测了免疫治疗反应的改善.
结论:
- 建立了一个整合性,机器学习优化的3基因预后模型,具有跨平台可靠性.
- EGR3作为瘤抑制和免疫调节的双重调节器,代表了一个新的治疗点.
- EGR3对治疗乳腺癌充满希望,特别是在免疫学上"冷"的三阴性亚型中.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K


